London scientists will launch a clinical trial of a transplant that they believe could help to treat advanced liver disease — the third biggest cause of death in adults of working age.
The Promise trial, led by researchers at King’s College London, will test whether giving liver disease patients “crapsule” pills containing freeze-dried stool from healthy volunteers could help reduce their likelihood of developing a painful or deadly infection.
